Form 13-F position report

MIRAGEN THERAPEUTICS INC

Reported by MILLENNIUM MANAGEMENT LLC

VRDN CUSIP 60463E103 Manager CIK 0001273087

Reported 0 shares, down 13,739 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q2 2020
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 10 Through Q2 2020

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value

Quarterly position history

How this manager's reported quarter-end position changed over time.

0 quarters
Quarterly reported position history for MIRAGEN THERAPEUTICS INC held by MILLENNIUM MANAGEMENT LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
This position's reported history falls outside the five-year preview window. A free account unlocks it. Unlock full history

Who else reported the position

34 managers reported MIRAGEN THERAPEUTICS INC for Q2 2020.

Managers reporting MIRAGEN THERAPEUTICS INC in Q2 2020.
Manager Activity Shares Change % of reported 13F Reported value Tenure
FMR LLC Unchanged 3,888,656 0 < 0.01% $4,316,000 14 qtrs
Atlas Venture Advisors Inc Unchanged 3,142,580 0 0.89% $3,488,000 7 qtrs
VANGUARD GROUP INC Reduced 1,584,420 -26,323 < 0.01% $1,759,000 14 qtrs
RENAISSANCE TECHNOLOGIES LLC Reduced 555,726 -48,400 < 0.01% $617,000 7 qtrs
BlackRock Inc Added 549,674 +109,418 < 0.01% $610,000 13 qtrs
JPMorgan Chase & Co Unchanged 319,344 0 < 0.01% $354,000 12 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 176,340 +21,621 < 0.01% $195,000 14 qtrs
Squarepoint Ops LLC Added 119,128 +51,870 < 0.01% $132,000 2 qtrs
Game Plan Financial Advisors LLC Added 69,550 +25,000 0.11% $77,000 3 qtrs
ACADIAN ASSET MANAGEMENT LLC New 64,167 +64,167 < 0.01% $71,000 1 qtr
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2020
Filed
August 14, 2020
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.